Better Labels for Nicotine in Vaping Products
Using Novel Labeling to Improve Public Understanding of Nicotine in Electronic Nicotine Delivery Systems (ENDS): Nicotine Concentration and Nicotine Flux
This project aims to create clearer labels for nicotine in vaping products to help adults make informed choices and discourage youth from starting.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11131102 on NIH RePORTER |
What this research studies
Many adults who vape also smoke, and young people are increasingly using vaping products, often without understanding the nicotine content. Current nicotine labels on vaping products are often confusing for both adults and youth. This work will develop new, easy-to-understand labels that clearly show the nicotine strength and how much nicotine is released. The goal is to help adult smokers who want to switch to vaping choose products with enough nicotine to help them quit cigarettes, while also deterring youth from using high-nicotine products and becoming dependent.
Who could benefit from this research
Good fit: Ideal participants for related future studies might include adults who use vaping products, adult smokers considering switching to vaping, or young adults willing to provide feedback on label clarity.
Not a fit: Individuals who do not use nicotine products or are not interested in understanding nicotine labeling for vaping products would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to clearer product information, helping adult smokers transition away from cigarettes and potentially reducing nicotine dependence among young people.
How similar studies have performed: Previous pilot work by this team has shown that new nicotine concentration labels can improve users' understanding of nicotine strength and addictiveness in vaping products.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Morean, Meghan E — Yale University
- Study coordinator: Morean, Meghan E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.